共 33 条
- [33] An open label trial comparing the effects of IFNB-1a (Rebif®), (Avonex®), IFNB-1b (Betaferon®) and glatiramer acetate (Copaxone®) on the relapse rate, lesion load on MRI and disease progression in patients with relapsing-remitting multiple sclerosis MULTIPLE SCLEROSIS JOURNAL, 2006, 12 : S194 - S194